Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
7.14
-0.15 (-2.03%)
Dec 27, 2024, 4:00 PM EST - Market closed
Burning Rock Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 510.89 | 537.44 | 563.24 | 507.86 | 429.9 | 381.68 | Upgrade
|
| Revenue Growth (YoY) | -8.54% | -4.58% | 10.90% | 18.13% | 12.64% | 82.74% | Upgrade
|
| Cost of Revenue | 159.79 | 174.21 | 183.2 | 143.72 | 115.98 | 108.34 | Upgrade
|
| Gross Profit | 351.09 | 363.23 | 380.04 | 364.15 | 313.92 | 273.33 | Upgrade
|
| Selling, General & Admin | 539.84 | 685.53 | 938.58 | 793.35 | 462.39 | 285.49 | Upgrade
|
| Research & Development | 253.21 | 347.02 | 421.87 | 367.86 | 263.94 | 156.94 | Upgrade
|
| Operating Expenses | 793.05 | 1,033 | 1,360 | 1,161 | 726.33 | 442.43 | Upgrade
|
| Operating Income | -441.96 | -669.32 | -980.41 | -797.06 | -412.41 | -169.09 | Upgrade
|
| Interest Expense | - | - | - | -1.54 | -0.67 | -8.99 | Upgrade
|
| Interest & Investment Income | 15.94 | 17.96 | 9.36 | 3.46 | 6.07 | 11.16 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.4 | -0.42 | 1.55 | -0.85 | -2.85 | 1.49 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.51 | 0.48 | 0.25 | 0.2 | 2.62 | -3.72 | Upgrade
|
| Pretax Income | -425.9 | -651.3 | -969.25 | -795.8 | -407.24 | -169.16 | Upgrade
|
| Income Tax Expense | 1.64 | 2.39 | 1.99 | 0.9 | - | - | Upgrade
|
| Net Income | -427.55 | -653.69 | -971.23 | -796.7 | -407.24 | -169.16 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 64.69 | 165.01 | Upgrade
|
| Net Income to Common | -427.55 | -653.69 | -971.23 | -796.7 | -471.92 | -334.17 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 7 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 7 | 2 | Upgrade
|
| Shares Change (YoY) | 0.30% | -1.46% | -0.29% | 51.83% | 192.26% | 4.94% | Upgrade
|
| EPS (Basic) | -41.63 | -63.84 | -93.47 | -76.45 | -68.76 | -142.30 | Upgrade
|
| EPS (Diluted) | -41.63 | -63.84 | -93.47 | -76.45 | -68.76 | -142.30 | Upgrade
|
| Free Cash Flow | -135.45 | -263.89 | -527.1 | -688.81 | -149.12 | -273.37 | Upgrade
|
| Free Cash Flow Per Share | -13.19 | -25.77 | -50.73 | -66.10 | -21.73 | -116.41 | Upgrade
|
| Gross Margin | 68.72% | 67.59% | 67.47% | 71.70% | 73.02% | 71.61% | Upgrade
|
| Operating Margin | -86.51% | -124.54% | -174.07% | -156.94% | -95.93% | -44.30% | Upgrade
|
| Profit Margin | -83.69% | -121.63% | -172.44% | -156.87% | -109.77% | -87.55% | Upgrade
|
| Free Cash Flow Margin | -26.51% | -49.10% | -93.58% | -135.63% | -34.69% | -71.62% | Upgrade
|
| EBITDA | -302.48 | -537.87 | -859.66 | -752.46 | -379.95 | -138.27 | Upgrade
|
| EBITDA Margin | -59.21% | -100.08% | -152.63% | -148.16% | -88.38% | -36.23% | Upgrade
|
| D&A For EBITDA | 139.48 | 131.45 | 120.75 | 44.6 | 32.46 | 30.82 | Upgrade
|
| EBIT | -441.96 | -669.32 | -980.41 | -797.06 | -412.41 | -169.09 | Upgrade
|
| EBIT Margin | -86.51% | -124.54% | -174.07% | -156.94% | -95.93% | -44.30% | Upgrade
|
| Revenue as Reported | 537.44 | 537.44 | 563.24 | 507.86 | 429.9 | 381.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.